Provided by Tiger Fintech (Singapore) Pte. Ltd.

Foghorn Therapeutics Inc.

6.19
0.0000
Post-market: 6.420.2300+3.72%19:55 EDT
Volume:82.02K
Turnover:502.88K
Market Cap:345.04M
PE:-4.62
High:6.39
Open:6.21
Low:6.00
Close:6.19
Loading ...
May 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 28, 2021

Major Issues Report

8-K - Current report
Apr 19, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 23, 2021

Major Issues Report

8-K - Current report
Mar 18, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 18, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 15, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Dec 04, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 04, 2020

Major Issues Report

8-K - Current report
Nov 25, 2020

Major Issues Report

8-K - Current report
Oct 29, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Oct 27, 2020

Major Issues Report

8-K - Current report
Oct 22, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 20, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 20, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 19, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933